EVALUATION OF ANTICANCER POTENTIAL OF ETHANOLIC EXTRACT OF ALANGIUM SALVIFOLIUM LEAVES IN ANIMAL MODELS by C, PRATHIMA et al.
Vol 12, Issue 2, 2019
Online - 2455-3891 
Print - 0974-2441
EVALUATION OF ANTICANCER POTENTIAL OF ETHANOLIC EXTRACT OF ALANGIUM 
SALVIFOLIUM LEAVES IN ANIMAL MODELS
PRATHIMA C1*, SHASHIKUMARA2, THIPPESWAMY T3
1Department of Pharmacology, JSS Medical College, JSS Academy of Higher Education and Research, Mysuru, Karnataka, India. 
2Department of Pharmacology, Chamarajanagar Institute of Medical College, Yadapura, Karnataka, India. 3Department of General 
Medicine, JSS Medical College, JSS Academy of Higher Education and Research, Mysuru, Karnataka, India. Email: prathimac@jssuni.edu.in
Received: 08 September 2018, Revised and Accepted: 02 November 2018
ABSTRACT
Objective: The present study aims to evaluate the anticancer potential of ethanolic extract of Alangium salvifolium leaves (EASL) against Ehrlich 
ascites carcinoma (EAC) in animal model.
Methods: The ethanolic extract of A. salvifolium was prepared by continuous method using Soxhlet apparatus. Phytochemical analysis of EASL was 
conducted. Anticancer activity of the extract was evaluated by EAC model in Swiss albino mice. EASL was administered at the doses of 100 and 
200 mg/kg body weight once a day orally for 14 days, after 24 h of tumor inoculation.
Results: A. salvifolium leaves extract treatment produced significant decrease in tumor volume and body weight, and increase in total and non-
viable cell count, along with elevated life span of EAC-bearing mice. The EASL exhibited potent dose-dependent antitumor activity. Further, the 
altered hematological parameters such as red blood cells, hemoglobin, and white blood cells levels as well as biochemical parameters such as serum 
glutamic oxaloacetic transaminase, serum glutamate pyruvate transaminase, alkaline phosphatase, albumin, and total protein levels in EAC mice were 
significantly (p<0.05) regained following treatment with EASL. The anticancer potential of EASL can be attributed to the presence of phenols and 
flavonoids.
Conclusion: Results suggest that EASL possesses significant anticancer activity against EAC tumor-bearing Swiss albino mice.
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INTRODUCTION
Cancer is one of the most life-threatening diseases and a serious public 
health problem in both developed and developing countries. It is one 
of the leading causes of mortality worldwide. Cancer is a group of 
diseases characterized by the deregulated proliferation of abnormal 
cells that invade and disrupt surrounding tissues [1]. The reports from 
the International Agency for Cancer Research in 2008 indicated that 
there are approximately 12 million new cancer cases every year with 
7 million cancer deaths within 5 years of diagnosis and about 25 million 
persons are living with cancer [2]. By 2030, it is estimated that there 
will be 26 million new cases diagnosed and 17 million cancer deaths 
annually [3]. Increasing interest and research on herbal medicine have 
revealed its importance in treating many diseases including cancer [4].
In the treatment of cancer, many synthetic and chemotherapeutic agents 
developed show various side effects such as alopecia, skin eruptions, 
reduced immunity, and secondary carcinogenesis [5]. Furthermore, 
there are treatment failures due to genetic mutations, drug resistance, 
etc. [5]. Hence, there is a need to develop newer, effective, and less 
toxic anticancer therapies. Ancient Indian medicinal science which 
was based on the natural products of plant origin was known to be 
effective against many cancers. Various medicinal plants are widely 
used in India as folk remedies or by different indigenous systems of 
medicine against different types of cancers. At present, research on 
anticancer drug development is largely focused on exploring potential 
phytochemicals [6].
Alangium salvifolium (Alangiaceae) is a small tree or shrub used as folk 
remedies in different indigenous systems of medicine such as Siddha, 
Unani, and Ayurveda and is native to South India, China, the Philippines, 
and Ceylon. The plant A. salvifolium has alternate leaves usually unequal 
about 12.5–17 cm long, 2.5–7.0 cm broad, oblong-lanceolate or oblong-
oval, acute or rounded at base, more or less acuminate, and obtuse at 
apex with 3–6 pairs of very oblique veins which are prominent beneath 
with white or yellowish-white fragrant flowers [7]. The different 
extracts of A. salvifolium contain phenolic compounds, flavonoids, 
alkaloids (ipecac and benzopyridoquinolizidine) carbohydrates, 
amino acids and volatile oil, alangine, lamarckinine, markindine, 
and emetine, tetrahydroisoquinoline monoterpene glycosides, 
phenolic glycosides, salviifosides A-C, salicin, kaempferol, and 
kaempferol 3-O-b-D-glucopyranoside [7].
The plant is known to possess various pharmacological activities 
such as antibacterial, antifungal, anti-inflammatory, antifertility, and 
antianxiety [7]. The chloroform extract of the flowers of A. salvifolium is 
known to possess antioxidant and anticancer activities [8]. Methanolic 
extract of A. salvifolium is known to possess significant antitumor 
activity in potato tumor assay [9]. Ethanolic extracts of A. salvifolium 
also exhibited protective role against CCL4-induced hepatic damage by 
its free radical scavenging property [10]. Hence, the present study was 
undertaken to evaluate the anticancer potential of the ethanolic extract 
of A. salvifolium leaves (EASL) by in vivo EAC model in Swiss albino mice.
METHODS
Plant materials and preparation of drug solution
A. salvifolium leaves were collected from Bannari Hill (Dhimbam), 
Coimbatore district, Tamil Nadu state, and it was authenticated by 
Dr. Mrutyunjaya (Prof, Dept. of Pharmacognosy, JSS Pharmacy College, 
Mysore). The leaves were subjected to wash with 70% alcohol and 
made into coarse powder after a shade dry for 1 week. About 500 g of 
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this powder was subjected to Soxhlet extraction for 12 h using ethanol 
as a solvent under suitable temperature. The extract was further 
concentrated using vacuum extractor for complete removal of the 
ethanol (absolute, ≥99.5%). The concentrated ethanolic EASL was used 
to evaluate the anticancer activity. Stock solution was freshly prepared 
using normal saline as solvent before dosing from which the different 
doses were administered by selecting the appropriate concentration.
Phytochemical screening
The freshly prepared extract of the leaves of A. salvifolium was 
subjected to phytochemical screening tests for the detection of various 
constituents [11].
Chemicals
The chemicals, ethanol, normal saline,  phosphate-buffered saline, trypan 
blue dye and cisplatin were obtained from the indicated commercial 
sources. All the reagents used were of analytical reagent grade.
Animals
Swiss albino mice weighing 25–30 g of either sex were procured from 
the Central Animal Facility of the Institute and maintained under the 
standard conditions: Room temperature (25±3)°C, humidity 45–55%, 
and 12/12 h light/dark cycle. They were fed with commercially available 
mouse pellet diet and water was allowed ad libitum. The experimental 
protocols were approved by the Institutional Animal Ethical Committee 
of JSS Medical College, Mysuru (261/PO/ReBi/2000/CPCSEA), and 
procedures in this study were performed in accordance with guidelines 
of Committee for the Purpose of Control and Supervision of Experiments 
on Animals.
Acute toxicity study
According to OECD 423 guidelines, healthy adult male Swiss albino 
mice starved overnight were divided into six groups (n=12) and were 
orally fed with increasing doses of EASL. Total EASL administered orally 
in doses of up to 2000 mg/kg did not produce any sign of toxicity and 
mortality in mice when observed for 14 days after administration. 
Based on preliminary toxicity study, the dose of our further study was 
determined between 100 and 300 mg/kg.
Animal grouping and treatment schedule
Animals (n=12) were randomly divided into six groups and received 
respective drugs 24 h after EAC transplantation:
• Group 1: Normal group was treated with normal saline (10 ml/kg) 
without EAC cells
• Group 2: Control group was treated with normal saline (10 ml/kg) 
with EAC cells
• Group 3: Test Group-I - standard group treated with drug cisplatin 
(3.5 mg/kg i.p.)
• Group 4: Test Group-II - EASL (100 mg/kg p.o)
• Group 5: Test Group-III - EASL (200 mg/kg p.o)
• Group 6: Test Group-IV - cisplatin (1.75 mg/kg i.p.) + EASL 
(100 mg/kg p.o).
Ehrlich ascites carcinoma (EAC)-induced tumor model
Tumor cells
EAC cells obtained from JSS College of Pharmacy, Mysore, Karnataka, 
India. The procured EAC cells were maintained by intraperitoneal 
inoculation of 2×106 cells/mouse. EAC cells aspirated from the 
peritoneal activity of mice were washed with saline and were injected 
intraperitoneally to induce ascitic fluid tumor in the test group 
animals.
Transplantation of EAC
All the animals were injected with EAC cells (0.2 ml of 2×106 cells/mouse) 
intraperitoneally except the normal group, for the development of ascites 
tumor [12]. After 24 h of tumor inoculation, the extracts of A. salvifolium 
in variable doses of 100 mg/kg and 200 mg/kg were administered once 
daily for 14 days to Groups IV–VI. After the last dose and 24 h of fasting, 
six mice from each group were sacrificed. Other animals in the groups 
were maintained with food and water ad libitum for survival studies.
Tumor growth response
The anticancer effect of EASL was assessed by tumor volume, increase 
in body weight, total and non-viable cell count, median survival time 
(MST), and percentage increased life span (%ILS). MST for each group 
was noted and anticancer activity of the test compounds was compared 
with that of control group by measuring %ILS [13].
MST = (Day of first death + day of last death)/2
ILS (%) =  ([MST of treated group mice/MST of control group mice]-1) 
×100.
The viability and non-viability of the cells were checked by trypan blue 
assay. The cells were stained with trypan blue (0.4% in normal saline) 
dye. The cells that did not take up the dye were viable and those that took 
the dye were nonviable. These viable and non-viable cells were counted.
Hematological and biochemical studies
On the past day of the experiment, after an overnight fasting blood was 
collected through tail vein for the estimation of hemoglobin (Hb) level, 
red blood cell (RBC), white blood cell (WBC) counts, and biochemical 
parameters: Serum glutamate oxaloacetate transaminase, serum 
glutamate pyruvate transaminase (SGPT), alkaline phosphatase (ALP), 
total proteins, and albumin by standard procedures.
Statistical analysis
The results were computed using GRAPH PRISM PAD version 7 software, 
one-way ANOVA test followed by post hoc Tukey’s multiple comparison 
tests were applied for analysis. Observations were expressed as 
mean ± SEM. The differences between means were considered to be 
statistically significant at p<0.05 (95% confidence individuals).
RESULTS
Phytochemical screening test
The freshly prepared extract of the leaves of A. salvifolium was subjected 
to phytochemical screening tests for the detection of various active 
constituents. The extract showed the presence of alkaloids, tannins, 
steroids, phenols, flavonoids, carbohydrates, and glycosides in crude 
ethanolic EASL as depicted in Table 1.
Anticancer activity
Toxicity evaluation
In the acute toxicity study, no mortality occurred within 72 h and till 
14 days under the tested doses. The maximal tolerated dose of ethanolic 
extract of AP was found to be >2000 mg/kg. On the basis of toxicological 
data, therapeutic doses were selected (Tables 2 and 3).
DISCUSSION
Recently, the alternative cancer therapies with the herbal medicines are 
gaining importance even as adjuvant to the chemotherapeutic drugs 
Table 1: Result of chemical group tests of the ethanolic EASL
EE Carbohydrates Tannins Flavonoid Saponin Phenols Steroids Alkaloids Glycosides
A. salvifolium ++ ++ ++ - ++ + +++ +++
EASL: Extract of Alangium salvifolium leaves, EE: Ethanolic extract, (+): Present, (-): Absent, (+++): Reaction intensity is high, (++): Reaction intensity is 
medium, (+): Reaction intensity is normal
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from the point of less toxic effects and cost benefits. In the present 
study, we evaluated the anticancer potential of A. salvifolium leaves 
which is used in ayurvedic system of medicine for various purposes.
The extract revealed the presence of various phytochemicals such as 
reducing sugars, flavonoids, phenols, tannins, steroids, alkaloids, and 
glycosides (Table 1). Previous articles have proved that leaves extract of 
A. salvifolium was safe up to the dose of 2000 mg/kg (p.o) body weight 
in mice [14]. Phytoconstituents like flavonoids, alkaloids, and steroids 
are known to possess anticancer activity, while flavonoids are shown to 
have antimalignant and antimutagenic properties [15]. In the present 
study, EASL has shown potent dose-dependent anticancer activity in 
EAC-bearing mice.
Treatment with EASL in the dose of 100 and 200 mg/kg body weight 
ILS and non-viable cell count and reduced the tumor volume and 
body weight significantly when compared to that of EAC control group 
(Table 2). Prolongation of life span and decrease in WBC cell count are 
reliable criteria for assessing the anticancer potential of any drug. Hence, 
it may be concluded that the extract by direct cytotoxic effects and by 
increasing the lifespan possess anticancer property. Myelosuppression 
and anemia are the major problems in cancer chemotherapy. Anemia 
in tumor-bearing mice may be due to iron deficiency, hemolytic, or 
myelopathic condition [16]. Treatment with EASL restored the Hb levels, 
RBC and WBC counts to near normal levels (Table 2), which indicates 
that the extract may possess protective effect on hematopoietic system.
Hepatotoxicity noted with anticancer chemotherapeutic agents 
may result due to their direct cytotoxic effects or due to their toxic 
metabolites. Elevated levels of biochemical parameters SGOT, SGPT, and 
ALP along with lowered levels of total proteins and albumin are noted 
in tumor-bearing mice [17]. In the present investigation, EASL restored 
these parameters toward normal levels, indicating hepatoprotective 
activity of EASL extract.
Previous studies have reported the significant anticancer activity of 
the crude extract of A. salvifolium flowers probably due to the presence 
of alkaloids, flavonoids, phenols, and terpenoids. Our study showing 
significant anticancer potential of ethanolic EASL is in concurrence 
with the study. The results of the present study are also consistent 
with the earlier report, which proved significant antitumor activity 
of the methanolic extract of A. salvifolium plant (200 and 400 mg/kg) 
against Dalton’s ascitic lymphoma. The anticancer activities of ethanolic 
EASL are probably due to the presence of flavonoids, phenols, tannins, 
steroids, and alkaloids.
CONCLUSION
The present study demonstrates the potent anticancer activity of 
A. salvifolium leaves extract. Further studies on the elucidation of its 
mechanism of action and the isolation of its active constituents may 
prove rewarding in cancer treatment.
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